| References |
| 1 |
Potent inhibitory effects of tyrosine metabolites on dihydropteridine reductase from human and sheep liver
|
| 2 |
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
|
| 3 |
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review J Psychiatry Neurosci. 1992 Nov;17(5):206-14.
|
| 4 |
Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate
|
| 5 |
Biotransformation of two citrus flavanones by lactic acid bacteria in chemical defined medium
|
| 6 |
4-n-nonylphenol degradation by the genus Metarhizium with cytochrome P450 involvement
|
| 7 |
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev. 2007 Jun;59(2):125-50.
|
| 8 |
Membrane bound catechol-O-methytransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain
|
| 9 |
DrugBank(Pharmacology-Metabolism)Levodopa
|
| 10 |
Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs
|
| 11 |
Catabolism of L-phenylalanine and L-tyrosine by Rhodobacter sphaeroides OU5 occurs through 3,4-dihydroxyphenylalanine Res Microbiol. 2007 Jul-Aug;158(6):506-11. doi: 10.1016/j.resmic.2007.04.008.
|
